Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologies Genmab secures rights for conducting research on ADCs against multiple drug targets with options for exclusive worldwide development and commercialization of resulting therapies Synaffix to receive an upfront payment of USD $4.5 million with a total deal value of up to USD $415 million plus […]
LONDON and RALEIGH, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm. D., President and Chief Executive Officer, will present a company overview at the H.C. Wainwright BioConnect Virtual Conference. The presentation will be available on-demand starting […]
Copenhagen, Denmark – Novo Holdings, a leading international life sciences investor, today announced that it has invested in Sound Bioventures Fund I as cornerstone investor in the first close of EUR 110 million. Sound Bioventures will be investing in private biotech companies and will focus on companies with assets in clinical or late pre-clinical stages, primarily […]
Novo Holdings A/S (“Novo Holdings”) today announced that it has agreed to acquire Ritedose from AGIC Capital and Humanwell. Founded in 1995 and headquartered in Columbia, S.C., The Ritedose Corporation (“Ritedose”) is a leading sterile pharmaceutical manufacturer, specialising in the use of blow-fill-seal (BFS) technology. Ritedose provides outsourced development and manufacturing of ophthalmology drugs, respiratory […]
The use of a biotechnology-based and certified-vegan silk-like fabric marks a first in the automotive sector Partnership with market leader underscores application potential of AMSilk’s technology AMSilk GmbH (“AMSilk”), a world leader in supplying innovative high-performance bio-based silk materials, today announces that it has entered a partnership with Mercedes-Benz, for the development of novel, sustainable […]
